Hearts and Minds Investments Ltd (AU:HM1) has released an update.
Hearts and Minds Investments Ltd reported a positive performance in May 2024, with a portfolio return of 0.5% for the month and an annualised return of 9.3% since inception in November 2018, alongside fully franked dividends totaling 53 cents per share. The company highlighted Telix Pharmaceuticals as a standout in their portfolio, showing a significant share price increase and strong commercial progress in the prostate imaging market. Additionally, the firm revealed an upcoming IPO for portfolio investment Guzman Y Gomez Limited, with offered share prices indicating a positive impact on HM1’s net asset value per share.
For further insights into AU:HM1 stock, check out TipRanks’ Stock Analysis page.
